pregnancy
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Pregnant women who currently taking or have taken Levofloxacin during the first trimester (include in taking Levofloxacin alone or with other medicine for combination treatment); 2. Pregnant women who volunteered to participate in this study with informed consent.
Exclusion criteria
Exclusion criteria: 1. Pregnant women who can't provide accurate information of using time and dosage of Levofloxacin; 2. Pregnant women who currently taking or have taken Levofloxacin during the second, third trimesters; 3. Pregnant women with mental illness or physical disability; 4. Women who have completed their pregnancy or women who are planning to become pregnant.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| congenital defect;birth length;Fetal femur length; | — |
Secondary
| Measure | Time frame |
|---|---|
| spontaneous abortion;induced abortion;adverse events of fetus;premature labour;adverse events of neonatus;birth weight;Apgar scores;adverse events of infant;adverse events of children;adverse events of teenagers; | — |
Countries
China
Contacts
Women's Hospital School of Medicine Zhejiang University